MNKDHealthcare · Biotechnology
MannKind Corporation
DeepValues Research covers MannKind (MNKD) with 1 research report since Mar 28, 2026. The latest Deep Value Intelligence report (Mar 28, 2026) ends with a Neutral stance (2.63/5). Sector: Healthcare · Biotechnology.
Research timeline
-
Deep Value Intelligence
MannKind Corporation (MNKD) Deep Value Intelligence ReportNeutral (2.63/5) on MannKind (MNKD), Mar 28, 2026. Price $2. MannKind shows elements of an interesting drug-delivery platform, but the current business…
Compare with other Healthcare companies
All Healthcare stocks| Company | Latest stance | Reports |
|---|---|---|
| MNKDMannKind | Neutral2.63 | 1 |
| ALLOAllogene Therapeutics | Bearish3.10 | 1 |
| MRNA | Neutral3.01 | 1 |
| CRSPCRISPR Therapeutics | Neutral2.30 | 1 |
| INSMInsmed | Bearish2.52 | 1 |
| GMABGenmab A/S | Bearish4.01 | 1 |
| TPSTTempest Therapeutics | Bearish2.65 | 1 |
| ADMAADMA Biologics | Neutral3.37 | 1 |
| LENZLENZ Therapeutics | Bearish3.12 | 1 |
Charts from the latest report
Open report
